earnings
confidence high
sentiment positive
materiality 0.75
Solventum Q2 sales up 3.9% to $2.2B; raises FY organic growth & EPS guidance
Solventum Corp
2025-Q2 EPS reported
$1.30
revenue$4,231,000,000
- GAAP diluted EPS $0.51; adjusted diluted EPS $1.69 (+8.3% YoY).
- Organic sales +2.8%; all segments positive, led by MedSurg and HIS.
- Adjusted operating margin expanded 120 bps to 21.9%.
- FY 2025 organic sales guidance raised to +2.0%-3.0%; EPS raised to $5.80-$5.95.
- Operating cash flow $169M; free cash flow $59M in Q2.